• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Welltower (WELL): Assessing Valuation After Strong FFO Growth and Improving Senior Housing Fundamentals

    Simply Wall St·12/10/2025 05:19:23
    Listen to the news

    Welltower (WELL) is drawing added attention after reporting more than 20% year-over-year growth in normalized FFO and roughly 15% same-store NOI, driven by stronger senior housing demand and improved occupancy.

    See our latest analysis for Welltower.

    Despite a softer 1 day share price return of negative 2.53 percent and a 7 day share price return of negative 3.03 percent, investors have enjoyed a 90 day share price return of 16.22 percent and a powerful year to date share price return of 56.99 percent. This is backed up by a striking 3 year total shareholder return of 212.11 percent that points to sustained momentum rather than a short lived bounce at the current 195.8 dollar share price.

    If Welltower’s run has you rethinking where healthcare real estate fits in your portfolio, it could be a good moment to explore other opportunities across healthcare stocks.

    With FFO surging, NOI accelerating, and the share price hovering just below analyst targets, investors now face a pivotal question: Is Welltower still trading below its long term potential, or is the market already pricing in years of future growth?

    Price-to-Earnings of 139.9x: Is it justified?

    On a price-to-earnings basis, Welltower’s 195.8 dollar share price screens as richly valued versus peers, signaling the market is paying a premium for its earnings.

    The price to earnings ratio compares what investors pay for each dollar of current earnings, a key yardstick for income generating real estate like health care REITs. For Welltower, a 139.9 times multiple suggests investors are willing to look well beyond today’s profitability in anticipation of stronger future cash flows from its senior housing and wellness platform.

    That premium is stark when set against both the sector and model based benchmarks. Compared with the Global Health Care REITs industry average of 25.9 times and a peer average of 60.8 times, Welltower’s multiple stands at more than double its closest peer group and over five times the broader health care REITs cluster. It also sits far above the estimated fair price to earnings ratio of 37.3 times. This level indicates where the market could gravitate if expectations cool or growth underwhelms.

    Explore the SWS fair ratio for Welltower

    Result: Price-to-Earnings of 139.9x (OVERVALUED)

    However, slowing revenue or net income growth, or a prolonged pullback from recent share price gains, could quickly challenge today’s premium valuation.

    Find out about the key risks to this Welltower narrative.

    Another View: What Does Our DCF Say?

    While the earnings multiple suggests a relatively expensive valuation, our DCF model is more measured. It indicates that Welltower is only slightly overvalued at 195.8 dollars compared with a fair value estimate of 191.85 dollars. If cash flows are broadly in line with forecasts, is today’s price really a deal breaker?

    Look into how the SWS DCF model arrives at its fair value.

    WELL Discounted Cash Flow as at Dec 2025
    WELL Discounted Cash Flow as at Dec 2025

    Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Welltower for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 100+ undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

    Build Your Own Welltower Narrative

    If you see the story differently or simply want to dig into the numbers yourself, you can easily craft a personalized view in minutes: Do it your way.

    A great starting point for your Welltower research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.

    Ready for your next investing move?

    Before you move on, consider scanning hand picked ideas on Simply Wall St so the next opportunity does not pass you by.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.